Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 1
1969 2
1982 1
1985 2
1986 1
1988 1
1990 1
2000 2
2002 1
2004 2
2006 1
2007 1
2008 1
2009 4
2010 1
2013 2
2014 3
2015 2
2016 2
2017 2
2018 3
2019 1
2020 3
2021 2
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Del Mastro L, Poggio F, Blondeaux E, De Placido S, Giuliano M, Forestieri V, De Laurentiis M, Gravina A, Bisagni G, Rimanti A, Turletti A, Nisticò C, Vaccaro A, Cognetti F, Fabi A, Gasparro S, Garrone O, Alicicco MG, Urracci Y, Mansutti M, Poletti P, Correale P, Bighin C, Puglisi F, Montemurro F, Colantuoni G, Lambertini M, Boni L; Gruppo Italiano Mammella Investigators. Del Mastro L, et al. Lancet Oncol. 2022 Dec;23(12):1571-1582. doi: 10.1016/S1470-2045(22)00632-5. Epub 2022 Nov 10. Lancet Oncol. 2022. PMID: 36370716 Clinical Trial.
Selective isolation of agents of chromoblastomycosis from insect-associated environmental sources.
Lima BJFS, Voidaleski MF, Gomes RR, Fornari G, Soares JMB, Bombassaro A, Schneider GX, Soley BDS, de Azevedo CMPES, Menezes C, Moreno LF, Attili-Angelis D, Klisiowicz DDR, de Hoog S, Vicente VA. Lima BJFS, et al. Among authors: fornari g. Fungal Biol. 2020 Mar-Apr;124(3-4):194-204. doi: 10.1016/j.funbio.2020.02.002. Epub 2020 Feb 12. Fungal Biol. 2020. PMID: 32220380
Sphingosine-1 phosphate induces cAMP/PKA-independent phosphorylation of the cAMP response element-binding protein (CREB) in granulosa cells.
Paradiso E, Lazzaretti C, Sperduti S, Antoniani F, Fornari G, Brigante G, Di Rocco G, Tagliavini S, Trenti T, Morini D, Falbo AI, Villani MT, Nofer JR, Simoni M, Potì F, Casarini L. Paradiso E, et al. Among authors: fornari g. Mol Cell Endocrinol. 2021 Jan 15;520:111082. doi: 10.1016/j.mce.2020.111082. Epub 2020 Nov 12. Mol Cell Endocrinol. 2021. PMID: 33189864
Molecular Epidemiology of Agents of Human Chromoblastomycosis in Brazil with the Description of Two Novel Species.
Gomes RR, Vicente VA, Azevedo CM, Salgado CG, da Silva MB, Queiroz-Telles F, Marques SG, Santos DW, de Andrade TS, Takagi EH, Cruz KS, Fornari G, Hahn RC, Scroferneker ML, Caligine RB, Ramirez-Castrillon M, de Araújo DP, Heidrich D, Colombo AL, de Hoog GS. Gomes RR, et al. Among authors: fornari g. PLoS Negl Trop Dis. 2016 Nov 28;10(11):e0005102. doi: 10.1371/journal.pntd.0005102. eCollection 2016 Nov. PLoS Negl Trop Dis. 2016. PMID: 27893750 Free PMC article.
Comparative Genomics of Sibling Species of Fonsecaea Associated with Human Chromoblastomycosis.
Vicente VA, Weiss VA, Bombassaro A, Moreno LF, Costa FF, Raittz RT, Leão AC, Gomes RR, Bocca AL, Fornari G, de Castro RJA, Sun J, Faoro H, Tadra-Sfeir MZ, Baura V, Balsanelli E, Almeida SR, Dos Santos SS, Teixeira MM, Soares Felipe MS, do Nascimento MMF, Pedrosa FO, Steffens MB, Attili-Angelis D, Najafzadeh MJ, Queiroz-Telles F, Souza EM, De Hoog S. Vicente VA, et al. Among authors: fornari g. Front Microbiol. 2017 Oct 9;8:1924. doi: 10.3389/fmicb.2017.01924. eCollection 2017. Front Microbiol. 2017. PMID: 29062304 Free PMC article.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
De Placido S, Gallo C, De Laurentiis M, Bisagni G, Arpino G, Sarobba MG, Riccardi F, Russo A, Del Mastro L, Cogoni AA, Cognetti F, Gori S, Foglietta J, Frassoldati A, Amoroso D, Laudadio L, Moscetti L, Montemurro F, Verusio C, Bernardo A, Lorusso V, Gravina A, Moretti G, Lauria R, Lai A, Mocerino C, Rizzo S, Nuzzo F, Carlini P, Perrone F; GIM Investigators. De Placido S, et al. Lancet Oncol. 2018 Apr;19(4):474-485. doi: 10.1016/S1470-2045(18)30116-5. Epub 2018 Feb 23. Lancet Oncol. 2018. PMID: 29482983 Clinical Trial.
Onychomycosis by Fusarium oxysporum probably acquired in utero.
Carvalho VO, Vicente VA, Werner B, Gomes RR, Fornari G, Herkert PF, Rodrigues CO, Abagge KT, Robl R, Camiña RH. Carvalho VO, et al. Among authors: fornari g. Med Mycol Case Rep. 2014 Oct 5;6:58-61. doi: 10.1016/j.mmcr.2014.09.005. eCollection 2014 Oct. Med Mycol Case Rep. 2014. PMID: 25383318 Free PMC article.
39 results